Joan Smith active positions
| Companies | Position | Start | End |
|---|---|---|---|
Surface Ventures
 Surface Ventures Investment ManagersFinance Surface Ventures (Surface Ventures) is a venture capital firm founded in 2020 by Gyan Kapur and Dimitri Boguslavsky. The firm is headquartered in New York. | Consultant / Advisor | 2020-08-31 | - |
Meliora Therapeutics, Inc.
 Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Meliora Therapeutics, Inc. is an American company that is revolutionizing cancer drug development by utilizing genomics and advanced computational methods as key components of their product development process. The company is based in California. The company has created "molecular fingerprints" for thousands of compounds to build an inference engine that identifies risk-adjusted small molecule compound and target mechanism of action (moa) pairs. This unique discovery engine has the potential for high clinical success. Meliora Therapeutics was founded in 2021 by Jason Sheltzer, Joan Smith, and David Li. David Li has been the CEO since 2021. | Chief Tech/Sci/R&D Officer | 2020-01-31 | - |
| Founder | 2020-01-31 | - |
Career history of Joan Smith
Training of Joan Smith
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Consultant / Advisor | 1 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Finance | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Surface Ventures
Surface Ventures Investment ManagersFinance Surface Ventures (Surface Ventures) is a venture capital firm founded in 2020 by Gyan Kapur and Dimitri Boguslavsky. The firm is headquartered in New York. | Finance |
Meliora Therapeutics, Inc.
Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Meliora Therapeutics, Inc. is an American company that is revolutionizing cancer drug development by utilizing genomics and advanced computational methods as key components of their product development process. The company is based in California. The company has created "molecular fingerprints" for thousands of compounds to build an inference engine that identifies risk-adjusted small molecule compound and target mechanism of action (moa) pairs. This unique discovery engine has the potential for high clinical success. Meliora Therapeutics was founded in 2021 by Jason Sheltzer, Joan Smith, and David Li. David Li has been the CEO since 2021. | Commercial Services |
- Stock Market
- Insiders
- Joan Smith
- Experience
